CIK 0001640266
- Accelerated filer
- Smaller reporting company
Voyager Therapeutics, Inc.
Sign in to watch- Ticker
- VYGR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-259-5340
- Business address
- 75 HAYDEN AVENUE, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-10 | EcoR1 Capital, LLC 10% owner | Sale | −336,400 | $8.05 | $2.7M | 3,961,507 |
| 2023-01-09 | EcoR1 Capital, LLC 10% owner | Sale | −456,000 | $7.67 | $3.5M | 4,297,907 |
| 2023-01-06 | Carter Todd Alfred Chief Scientific Officer | Sale | −388 | $6.41 | $2K | 36,194 |
| 2023-01-01 | Colon Grace Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2022-12-31 | Carter Todd Alfred Chief Scientific Officer | Grant or award | +388 | $5.17 | $2K | 36,582 |
| 2022-10-01 | PFREUNDSCHUH PETER P. Chief Financial Officer | Grant or award | +125,000 | 125,000 | ||
| 2022-09-19 | Carter Todd Alfred Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +165,000 | 165,000 | ||
| 2022-09-19 | PFREUNDSCHUH PETER P. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2022-08-25 | Third Rock Ventures III, L.P. 10% owner | Sale | −200,000 | $6.22 | $1.2M | 5,428,933 |
| 2022-08-24 | Third Rock Ventures III, L.P. 10% owner | Sale | −149,972 | $6.09 | $913K | 5,628,933 |
| 2022-08-16 | Third Rock Ventures III, L.P. 10% owner | Sale | −128,456 | $6.04 | $776K | 5,778,905 |
| 2022-08-15 | MACKEY CATHERINE J Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2022-08-15 | Third Rock Ventures III, L.P. 10% owner | Sale | −135,808 | $6.04 | $820K | 5,907,361 |
| 2022-08-12 | Third Rock Ventures III, L.P. 10% owner | Sale | −348,007 | $6.12 | $2.1M | 6,043,169 |
| 2022-07-14 | PIERCE GLENN Director | Sale | −9,512 | $6.70 | $64K | 16,788 |
| 2022-07-14 | Higgins Michael J Director | Sale | −13,891 | $6.70 | $93K | 31,314 |
| 2022-06-23 | EcoR1 Capital, LLC 10% owner | Purchase | +376,000 | $5.66 | $2.1M | 4,753,907 |
| 2022-06-21 | EcoR1 Capital, LLC 10% owner | Purchase | +101,400 | $5.28 | $536K | 4,377,907 |
| 2022-06-06 | GERAGHTY JAMES A Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2022-06-06 | Hyman Steven Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 |
Page 9 of 19 · 368 trades